Delivery Order SPE2DB22D2211-SPE2DB24FPBQ0

Award Date 8/5/24
Potential Completion Date 8/6/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4563118878 ONDANSETRON ODT 8 MG TABLET 30S. The contract is a Firm Fixed Price agreement with a ceiling value of $2,946.30 and an ultimate completion date of December 18, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4561655273 ONDANSETRON ODT 4 MG TABLET 30S. The firm-fixed-price contract has a ceiling value of $2,749.22 and an ultimate completion date of August 1, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4566877513 ONDANSETRON ODT 8 MG TABLET 30S. The contract has a ceiling value of $5,941.43 and runs through January 10, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp is the prime contractor, and this award is part of a larger Indefinite Delivery Contract (IDC) the company holds with the DLA Troop...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of ONDANSETRON ODT 4 MG TABLET 30S, a pharmaceutical product. The contract has a ceiling value of $3,907.34 and a period of performance running through March 10, 2025. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026. The IDC...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, Corporate Office Division, for the supply of 4565469311 - ONDANSETRON ODT 8 MG TABLET 30S. The award has a ceiling value of $8,711.53 and an ultimate completion date of August 16, 2024. The contract is a Firm Fixed Price type. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,912.52, is for the supply of 4567707435 ! ONDANSETRON ODT 4 MG TABLET 30S, a medical product. The contract has a firm fixed price and an ultimate completion date of March 27, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4567957745 ONDANSETRON ODT 4 MG TABLET 30S, a pharmaceutical product. The contract is not set aside and has a ceiling value of $1,293.48, with a period of performance through April 18, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ONDANSETRON ODT 4 MG TABLET 30S. The firm-fixed price contract has a ceiling value of $1,222.34 and a performance period ending on May 22, 2025. This award is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at $999,999,999.00, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ONDANSETRON ODT 8 MG TABLET 30S. The contract has a firm fixed price of $4,721.53 and a performance period ending on January 16, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4567090050 - ONDANSETRON ODT 8 MG TABLET 30S medical supplies. The contract has a ceiling value of $1,809.27 and runs through January 30, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB24FPBQ0
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4565354447 - ONDANSETRON ODT 8 MG TABLET 30S. The award has a ceiling value of $1,133.75 and is a firm fixed-price contract that runs through August 6, 2024. This order is under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 11/4/24, 11:32 AM